Medical Advisory Board Members

All advisory board members will assist with the annual stakeholder meeting; website outreach to professionals and patients; assist CCF to acquire CME funding to educate the general medical community; provide administrative guidance, assistance and strategic direction; other responsibilities to be determined.

Chair, Ghassan K. Abou-Alfa, MD

Ghassan K. Abou-Alfa is an appointed physician at Memorial Sloan-Kettering Cancer Center and associate professor of the Weill Cornell Medical College in New York. Dr. Abou-Alfa specializes in the treatment of gastrointestinal malignancies with a special focus on cholangiocarcinoma, biliary cancers, and hepatocellular carcinoma. Dr. Abou-Alfa received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine. His research is dedicated to finding novel therapies and improving the effectiveness current therapies for cholangiocarcinoma, biliary cancers and hepatocellular carcinoma, while continuing to understand the basic mechanisms of the diseases and its therapy. Dr Abou-Alfa has many publications in the field. He led on many occasions, international teams of investigators. Dr. Abou-Alfa serves as the chair of the National Cancer Institute (NCI) Task Force for...

Vice Chair, Juan Valle, MB ChB MSc FRCP

Professor Juan Valle is a Professor of Medical Oncology in the University of Manchester (Institute of Cancer Studies); part of the Manchester Academic Health Sciences Centre. He is based in the Department of Medical Oncology at The Christie NHS Foundation Trust within the Gastrointestinal Disease Group and treats cancers of the pancreas, liver and biliary tract, neuroendocrine tumours and colorectal cancer. He is Head of Service for The Christie Neuroendocrine Team which has, under professor Valle’s leadership, been recognised as a Centre of Excellence for the treatment of patients with neuroendocrine tumours (NETs) by ENETS (the European Neuroendocrine Tumour Society). Prof. Valle is a member of the UK National Cancer Research Network (NCRN) Upper Gastrointestinal Clinical Studies Group and member of the hepatobiliary and...

Jeff Geschwind, MD

Dr. Jean-Francois (Jeff) Geschwind is the Chairman and Chief of the Department of Diagnostic Radiology at the Yale School of Medicine. Dr. Geschwind’s clinical expertise focuses on treating hepatic cancer and other malignancies. He is considered a key opinion leader in the field of liver cancer. A native of France, Dr. Geschwind received his medical degree from Boston University School of Medicine in 1991. He performed his residency training as a research scholar (sponsored by the NIH) in diagnostic radiology at the University of California at San Francisco (UCSF) in 1996, where his research focused on cardiac magnetic resonance imaging. Dr. Geschwind completed his training in vascular and interventional radiology at Johns Hopkins and joined the faculty in 1998 as an Assistant Professor. Dr....

T. Peter Kingham, M.D.

T. Peter Kingham, M.D., is an Assistant Attending on the Hepatopancreatobiliary Service at Memorial Sloan Kettering Cancer Center. He completed fellowship at MSKCC and joined the faculty in 2010. In his clinical practice he treats patients with cancers of the liver, gallbladder, bile ducts, and pancreas. He specializes in minimally invasive surgical approaches to these cancers and the application of image guidance in the operating room. Dr. Kingham is a principle investigator or co-investigator on multiple clinical studies that concentrate on novel ways to treat patients with liver and pancreas cancers. These include studying circulating tumor DNA, circulating tumor cells, genetic signatures that can predict outcomes, and image guidance techniques. He is funded by the National Cancer Institute. Another aspect of Dr. Kingham’s career...

Lewis Roberts, MB, ChB, PhD

Dr. Lewis Roberts is a Professor of Medicine at Mayo Clinic in Rochester Minnesota. His research interests include studies of the molecular mechanisms of liver carcinogenesis; development of biomarkers and clinical tests to improve the diagnosis and treatment of liver, bile duct, and pancreas cancers; and improvements in prevention, diagnosis and treatment of hepatitis and liver cancer throughout the world. His research has been funded by the National Institutes of Health, The Robert Wood Johnson Foundation, and the Foundation for Digestive Health and Nutrition. Dr. Roberts also serves as President of Africa Partners Medical, a non-profit organization focused on improving healthcare delivery in Africa through medical education, practical skills training, and provision of medical equipment and...